Delivery Order SPE2DB20D2104-SPE2DB25FNBUU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,571.84 to AmerisourceBergen Drug Corp for Allegra-D 12 Hour Tablet 30-count units on June 3, 2025, with completion scheduled for June 4, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed price delivery order for pharmaceutical supplies to support federal medical procurement needs. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ALLEGRA-D 24 HOUR TABLET 15S, a pharmaceutical product, with a ceiling value of $1,316.96 and an ultimate completion date of May 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp under a firm fixed price contract for $534. The delivery order is for 30 boxes of Allegra-D 12 Hour tablets to be delivered to a location in Conshohocken, Pennsylvania by October 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a pharmaceutical distribution company. No set-aside provision was specified for this delivery order to fulfill the Defense Logistics Agency's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,453.83 firm fixed-price delivery order is for the supply of Allegra allergy 180 mg tablets. The contract has an ultimate completion date of January 23, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,180.52 delivery order contract is for the provision of Allegra Allergy 180 mg tablets, which are non-set-aside medical supplies. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $17,536.98 firm fixed price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 2, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed at the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $15,245.44 by the Defense Logistics Agency's Medical Supply Chain. The competitively awarded, firm fixed-price delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order...
- This is a Delivery Order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999. The Delivery Order, valued at $2,685.55, is for the pharmaceutical product "ALLEGRA ALLERGY 180 MG TABLET 45S" to support military healthcare programs. The contract is a Firm Fixed Price arrangement with an ultimate completion date of April 4, 2025. There is no set-aside designation for this award....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,207.80 on August 16, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by August 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,154.74 by the Defense Logistics Agency (DLA) on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price, competitively awarded contract (with no set-aside designation) covers the supply of pharmaceutical products and medical supplies, specifically identified as "4569610614 ! DT 1C 2.25X4 700/RL 6RL/BX DHAPCL" for delivery to Conshohocken, Pennsylvania. The award represents...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBUUDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,197.04 by the Defense Logistics Agency (DLA) on September 29, 2025, with an ultimate completion date of September 30, 2025. The delivery order, issued without set-aside designation, covers the supply of Allegra-D 24 Hour Tablet in quantities of 15 units. This award is issued as a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. As a child delivery order under the broader DLA pharmaceutical prime vendor contract, this award reflects AmerisourceBergen's established role as a critical supplier of pharmaceutical products and medical supplies to federal military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse medical procurement requirements across multiple therapeutic domains, with consistent awards structured as firm fixed-price delivery orders through open competition. This particular transaction represents one of numerous individual medication deliveries AmerisourceBergen executes through its DLA relationship to support Defense Health Agency operations and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/29/25 |